Oncotelic Launches AI-Powered GMP Manufacturing Services Platform at BIO International Convention 2026
Oncotelic Therapeutics launched its AI-powered GMP manufacturing services platform at the BIO International Convention, integrating its proprietary PDAOAI architecture with intelligent robotics from partner TechForce Robotics. The new platform targets pharmaceutical and biotechnology companies with capabilities for electronic batch records, AI-assisted documentation, and automated quality management.
Key figures
- Sapu003 phase
- Phase 1b
- Gmp bio ownership percent
- 45%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.